Karo Pharma AB buy Morgan Stanley
Start price
31.07.23
/
50%
€5.44
Target price
31.07.24
€30.83
Performance (%)
-
End price
01.08.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Karo Pharma AB | - | - | - | - |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% | 65.851% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% | 93.298% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% | 89.079% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% | 71.942% |
Comments by Morgan_Stanley for this prediction
In the thread Karo Pharma AB diskutieren
Karooooo Ltd. (NASDAQ: KARO) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $34.00 price target on the stock.
Ratings data for KARO provided by MarketBeat
In the thread Trading Karo Pharma AB
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten